| Literature DB >> 33553611 |
Zhao Lei1, Yang Zhang1, Gang Liu1.
Abstract
The clinical introduction of magnetic hyperthermia therapy (MHT) has been hindered by current available agents with poor magnetic-to-thermal conversion efficiency and biocompatibility. It is believed that the genetically engineered magnetic nanocages of encapsulin-produced magnetic iron oxide nanocomposites (eMIONs) have great potential as clinically translatable MHT agents for cancer magneto-catalytic theranostics.Entities:
Keywords: Magnetic hyperthermia therapy; biomineralization; iron oxide nanoparticles; nanocages
Year: 2021 PMID: 33553611 PMCID: PMC7849714 DOI: 10.1080/23723556.2020.1863739
Source DB: PubMed Journal: Mol Cell Oncol ISSN: 2372-3556